On January 6, 2025 Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA (Press release, Leap Therapeutics, JAN 6, 2025, View Sourcenews-releases/news-release-details/leap-therapeutics-participate-43rd-annual-jp-morgan-healthcare" target="_blank" title="View Sourcenews-releases/news-release-details/leap-therapeutics-participate-43rd-annual-jp-morgan-healthcare" rel="nofollow">View Source [SID1234649442]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Leap Presentation Details:

43rd Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 15, 2025
Time: 2:15 p.m. Pacific Time

A live webcast of the presentation may be accessed on the Investors page of the company’s website at View Source, where a replay of the events will also be available for a limited time.